Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 5Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 2Toxemia 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Glioblastoma 1Diabetes, Gestational 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Positron-Emission Tomography × Clear all
NCT05632601 2026-05-08

HER-CROWN

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
176 enrolled
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT00367666 2026-03-10

Using Diagnostic Tools to Stage Breast Cancer

University of Pennsylvania

Phase NA Active not recruiting
400 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡